[Latin Name] Amorphophallus konjac

[Plant Source] from China

[Specifications] Glucomannan85%-90%

[Appearance] White or cream-color powder

Plant Part Used:Root

[Particle size] 120 Mesh

[Loss on drying] ≤10.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

[Introduction]

Konjac is a plant that is found in China, Japan and Indonesia. The plant is part of the genus Amorphophallus. Typically, it thrives in the warmer regions of Asia.

The extract of the Konjac root is referred to as Glucomannan. Glucomannan is a fiber-like substance traditionally used in food recipes, but now it is utilized as an alternative means of weight loss. Along with this benefit, konjac extract contains other benefits for the rest of the body as well.

The main material of the natural konjac gum is fresh konjac, which grow in virgin forest in Hubei area. We use advanced method to distill the KGM, aminophenol, Ca, Fe, Se which are good for health. Konjac is known as“ the seventh nutriment for human”.

Konjac Gum with its special water holiding capacity, stability, emulsibility, thickening property,suspension property and gel propery can especially adopted in food industry.

[Main Function]

1.It could reduce postprandial glycemia, blood cholesterol and blood pressure.

2.It could control appetite and reduce body weight.

3.It could increase insulin sensitivity.
4.It could control insulin resistant syndrome and diabetesII development.
5.It could reduce heart disease.

[Application]

1) Gelatinizer(jelly, pudding, Cheese, soft candy, jam );

2) Stabilizer(meat, beer);

3) Film Former(capsule, preservative)

4) Water-keeping agent( Baked Foodstuff );

5) Thickener (Konjac Noodles, Konjac Stick, Konjac Slice, Konjac Imitating Food stuff);

6) Adherence agent( Surimi );

7) Foam Stabilizer (ice cream, cream, beer)

Title: Craft materials to overcome ocular barriers

4th International Conference on
Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore, USA

OMICS International: https://omicsonline.org
Vaccine Conferences: https://conferenceseries.com/immunology-conferences.php
Global Medical Conferences: https://conferenceseries.com
Global Pharmaceutical Conferences: https://pharmaceuticalconferences.com
Global Cancer Conferences: https://cancersummit.org

Global Diabetes Conferences: https://diabetesexpo.com
Global Dental Conferences: https://dentalcongress.com
Global Nursing Conferences: https://nursingconference.com

Abstract:

While new therapeutics are being developed for treating ocular diseases, the use of these therapeutics is still hampered by the need for more effective method of delivery. The reason is that these therapeutics have short half-lives, do not or hardly cross the cornea, the blood retinal barrier (BRB) and other ocular barriers, and can cause toxicity and side effects at high dose. In our Biomaterials for Translational Research Laboratory, we are interested in engineering multi-functional polymeric systems for targeted and sustained delivery of desired amount of drugs across ocular barriers to treat anterior and posterior eye diseases. In this talk, I will discuss our collaborative researches in developing i) hydrogels as subconjunctivally implantable delivery systems for sustained release of insulin to treat diabetic retinopathy; and ii) polysaccharide based nanoparticles for enhanced drug permeability across the cornea and the BRB to treat diabetic retinopathy, retinoblastoma, and glaucoma, etc.

Biography:

Tao Lowe is an Associate Professor of Pharmaceutical Sciences and Biomedical Engineering at University of Tennessee. Previously, she was an Assistant Professor of Surgery, Bioengineering, and Materials Science and Engineering, and Co-Director of the Integrated Graduate Degree Molecular Toxicology Program at Pennsylvania State University. She received her Ph.D. with an Eximia Cum Laude from the University of Helsinki, Finland, and conducted two years’ postdoctoral research in the Chemical Engineering Department at University of Wisconsin, Madison. She has published more than two dozen papers in reputed journals, and has given more than 150 presentations and 60 invited talks. She has trained ca. 60 students, including PhD, MD, MD/PhD, PharmD, and PharmD/PhD. She is a peer reviewer for more than 30 refereed journals, and serves on the editorial boards of 6 international journals. She has chaired more than 40 sessions at international conferences.

The New Industry Standard HPLCs
The HPLC system perfect for checking synthetic compounds, quantitative testing with standard operative procedures, etc. This system is suitable for a wide range of industries, such as pharmaceuticals, chemicals, foods and the environment. It can be operated as a single-use system or a shared system. Its small footprint facilitates the management and relocation of systems.

https://www.shimadzu.com/an/hplc/i-series/index.html